YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG: 1558)

YiChang HEC ChangJiang Pharmaceutical Revenue

YiChang HEC ChangJiang Pharmaceutical had revenue of 2.45B CNY in the half year ending June 30, 2024, with 89.80% growth. This brings the company's revenue in the last twelve months to 5.54B, down -2.13% year-over-year. In the year 2023, YiChang HEC ChangJiang Pharmaceutical had annual revenue of 6.29B with 68.08% growth.

• Revenue (ttm): 5.54B CNY
• Revenue Growth: -2.13%
• P/S Ratio: 1.42
• Revenue / Employee: 1.20M CNY
• Employees: 4,618
• Market Cap: 8.45B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.29B	2.55B	68.08%
Dec 31, 2022	3.74B	2.83B	309.83%
Dec 31, 2021	913.79M	-1.43B	-61.08%
Dec 31, 2020	2.35B	-3.88B	-62.27%
Dec 31, 2019	6.22B	3.71B	147.92%